Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women

International Journal of Infectious Diseases

Volumn 14, Issue 2, 2010, Pages

  Bayraktar, Mehmet Refik ^a   Ozerol, Ibrahim Halil ^a   Gucluer, Nilay ^a   Celik, Onder ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Antibiotic susceptibility; Low birth weight; Mycoplasma hominis; Spontaneous abortion; Ureaplasma urealyticum

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; JOSAMYCIN; OFLOXACIN; PRISTINAMYCIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; CANDIDA ALBICANS; GARDNERELLA VAGINALIS; LOW BIRTH WEIGHT; MICROBIAL COLONIZATION; MIXED INFECTION; MYCOPLASMA HOMINIS; MYCOPLASMOSIS; NEWBORN MORTALITY; OPPORTUNISTIC INFECTION; OUTPATIENT DEPARTMENT; PREGNANT WOMAN; PREVALENCE; SPONTANEOUS ABORTION; UREAPLASMA INFECTION; UREAPLASMA UREALYTICUM; UROGENITAL TRACT INFECTION;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM; UROGENITAL SYSTEM; YOUNG ADULT;

EID: 76449099079     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.03.020     Document Type: Article

References (27)

1. Cassell G.H., Waites K.B., Watson H.L., Crouse D.T., and Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 6 (1993) 69-87
2. Taylor-Robinson D., and Furr P.M. Update on sexually transmitted mycoplasmas. Lancet 351 Suppl 3 (1998) 12-15
3. Daxboeck F., Zitta S., Stadler M., Iro E., and Krause R. Mycoplasma hominis and Ureaplasma urealyticum in patients with sterile pyuria. J Infect 51 (2005) 54-58
4. Patai K., Szilágyi G., Hubay M., Szentmáriay I.F., and Paulin F. Severe endometritis caused by genital mycoplasmas after Caesarean section. J Med Microbiol 54 (2005) 1249-1250
5. Witt A., Berger A., Gruber C.J., Petricevic L., Apfalter P., Worda C., et al. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol 193 (2005) 1663-1669
6. Pararas M.V., Skevaki C.L., and Kafetzis D.A. Preterm birth due to maternal infection: causative pathogens and modes of prevention. Eur J Clin Microbiol Infect Dis 25 (2006) 562-569
7. van Belkum A., van der Schee C., van der Meijden W.I., Verbrugh H.A., and Sluiters H.J. A clinical study on the association of Trichomonas vaginalis and Mycoplasma hominis infections in women attending a sexually transmitted disease (STD) outpatient clinic. FEMS Immunol Med Microbiol 32 (2001) 27-32
8. Waites K.B., Katz B., and Schelonka R.L. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 18 (2005) 757-789
9. Zdrodowska-Stefanow B., Kłosowska W.M., Ostaszewska-Puchalska I., Bułhak-Kozioł V., and Kotowicz B. Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. Adv Med Sci 51 (2006) 250-253
10. Clegg A., Passey M., Yoannes M., and Michael A. High rates of genital Mycoplasma infection in the highlands of Papua New Guinea determined both by culture and by a commercial detection kit. J Clin Microbiol 35 (1997) 197-200
11. Domingues D., Távora Tavira L., Duarte A., Sanca A., Prieto E., and Exposto F. Genital mycoplasmas in women attending a family planning clinic in Guiné-Bissau and their susceptibility to antimicrobial agents. Acta Trop 86 (2003) 19-24
12. Keane F.E., Thomas B.J., Gilroy C.B., Renton A., and Taylor-Robinson D. The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners. Int J STD AIDS 11 (2000) 356-360
13. Arya O.P., Tong C.Y., Hart C.A., Pratt B.C., Hughes S., Roberts P., et al. Is Mycoplasma hominis a vaginal pathogen?. Sex Transm Infect 77 (2001) 58-62
14. Kenny G.E., and Cartwright F.D. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines and quinolones. Antimicrob Agents Chemother 45 (2001) 2604-2608
15. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., and Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1983) 14-22
16. Egan M.E., and Lipsky M.S. Diagnosis of vaginitis. Am Fam Physician 62 (2000) 1095-1104
17. Grattard F., Soleihac B., De Barbeyrac B., Bebear C., Seffert P., and Pozzetto B. Epidemiologic and molecular investigations of genital mycoplasmas from women and neonates at delivery. Pediatr Infect Dis J 14 (1995) 853-858
18. Kechagia N., Bersimis S., and Chatzipanagiotou S. Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece. J Antimicrob Chemother 62 (2008) 122-125
19. Kataoka S., Yamada T., Chou K., Nishida R., Morikawa M., Minami M., et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol 44 (2006) 51-55
20. McDonald H.M., O'Loughlin J.A., Jolley P.T., Vigneswaran R., and McDonald P.J. Changes in vaginal flora during pregnancy and association with preterm birth. J Infect Dis 170 (1994) 724-728
21. Kundsin R.B., Leviton A., Allred E.N., and Poulin S.A. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely. Obstet Gynecol 87 (1996) 122-127
22. McGregor J.A., and French J.I. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 55 Suppl 1 (2000) S1-19
23. Chaim W., Mazor M., and Leiberman J.R. The relationship between bacterial vaginosis and preterm birth. Arch Gynecol Obstet 259 (1997) 51-58
24. Taylor-Robinson D., and Bebear C. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother 40 (1997) 622-630
25. Semra Z., Rosenberg S., and Soffer Y. In vitro susceptibility of Mycoplasma hominis clinical isolates to tetracyclines, quinolones and macrolides. Diagn Microbiol Infect Dis 44 (2002) 359-361
26. Ullmann U., Schubert S., and Krausse R. Comparative in vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis. J Antimicrob Chemother 43 Suppl C (1999) 33-36
27. Bebear C.M., Renaudin H., Charron A., Gruson D., Lefrancois M., and Bebear C. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother 44 (2000) 2557-2560